Stafford brings to the Wyss over 10 years industrial experience in pharmaceutical development with extensive expertise in analytical development and product characterization. Prior to joining the Wyss, Stafford conducted and managed assay development, method validation, regulatory affairs, and quality control activities for a series of biotech and pharmaceutical companies advancing a wide range of therapeutic products through clinical trials to FDA approval. His research interests include: biomaterial engineering, nanobiotechnology, drug delivery, analytical development, method validation, and synthetic chemistry. Stafford received his B.S. in Chemistry from the University of California at Santa Cruz.